The United States home infusion therapy market is projected to reach approximately US$ 20.59 billion by 2033, up from US$ 10.26 billion in 2024, with a compound annual growth rate (CAGR) of 8.05% from 2025 to 2033. This growth is driven by the increasing prevalence of chronic diseases, advancements in home healthcare technology, and a rising preference for cost-effective, patient-centric treatment options. Read More: https://www.renub.com/united-states-home-infusion-market-p.php #United_States_Home_Infusion_Therapy_Market #United_States_Home_Infusion_Therapy_Market_Size #United_States_Home_Infusion_Therapy_Market_Trends